Addex Therapeutics

About:

Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.

Website: http://addextherapeutics.com

Twitter/X: addexpharma

Top Investors: New Enterprise Associates, Indivior, Innosuisse, EDBI, Biotechnology Value Fund

Description:

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Total Funding Amount:

$204M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Plan-les-ouates, Geneve, Switzerland

Founded Date:

2002-01-01

Contact Email:

info(AT)addextherapeutics.com

Founders:

Tim Dyer

Number of Employees:

11-50

Last Funding Date:

2024-01-31

IPO Status:

Public

Industries:

© 2025 bioDAO.ai